Trial
NCT06218667
A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
—
Condition
Prostate Cancer
Intervention
Copanlisib
Why stopped
Study drug not available per sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-31